Moneycontrol
HomeNewsBusinessCompaniesNatco to partner Lupin to market generic breast cancer drug
Trending Topics

Natco to partner Lupin to market generic breast cancer drug

Hyderabad-based Natco Pharma has filed an abbreviated new drug application with US Food and Drugs Administration for a generic version of Lapatinib Ditosylate tablets of 250 mg strength, used for the treatment of breast cancer. Natco said it has partnered with Lupin to market the product.

June 23, 2011 / 14:11 IST
Story continues below Advertisement

Moneycontrol Bureau

Hyderabad-based Natco Pharma has filed an abbreviated new drug application with US Food and Drugs Administration for a generic version of Lapatinib Ditosylate tablets of 250 mg strength, used for the treatment of breast cancer. Natco said it has partnered with Lupin to market the product.

Natco

first published: Jun 23, 2011 12:20 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!